Tiny tube offers new hope for stubborn glaucoma

NCT ID NCT07235592

Summary

This study is testing a small implant called the PRESERFLO MicroShunt XI in people with glaucoma whose eye pressure isn't well controlled by medications. The tiny tube helps drain fluid from the eye to lower pressure. Researchers will follow 112 patients for 12 months to see how safe and effective the implant is.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AKH Wien

    Vienna, Austria

    Contact

  • Glaucoma Clinic, UZ Leuven

    Leuven, Belgium

    Contact

  • Guy's and St. Thomas' NHS Foundation Trust

    London, United Kingdom

    Contact

  • Hospital Clinico San Carlos

    San Carlos, Spain

    Contact

  • Internationale Innovative Opthalmochirurgie GbR

    Düsseldorf, Germany

    Contact

  • Irccs Fondazione G. B. Bietti

    Rome, Italy

    Contact

  • Moorfields Eye Hospital NHS Foundation Trust

    London, United Kingdom

    Contact

  • Policlinico Universitario Molinette

    Turin, Italy

    Contact

  • ULS Santa Maria, Lisboa

    Lisbon, Portugal

    Contact

  • Universiteitskliniek voor Oogheelkunde Maastricht

    Maastricht, Netherlands

    Contact

  • Universitätsklinikum Tübingen, Department für Augenheilkunde

    Tübingen, Germany

    Contact

Conditions

Explore the condition pages connected to this study.